| Product Code: ETC7535917 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India acquired orphan blood diseases therapeutics market import shipment demonstrated robust growth with a significant CAGR from 2020 to 2024. However, the growth rate decelerated notably between 2023 and 2024. Overall, the market expanded vigorously but showed signs of slowing down towards the end of the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Acquired Orphan Blood Diseases Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Acquired Orphan Blood Diseases Therapeutics Market - Industry Life Cycle |
3.4 India Acquired Orphan Blood Diseases Therapeutics Market - Porter's Five Forces |
3.5 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.7 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume Share, By DistributionChannels, 2021 & 2031F |
3.8 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume Share, By Therapies Covered, 2021 & 2031F |
4 India Acquired Orphan Blood Diseases Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of acquired orphan blood diseases in India |
4.2.2 Growing awareness and diagnosis of rare diseases |
4.2.3 Advancements in medical research and technology for developing therapeutics |
4.3 Market Restraints |
4.3.1 Limited availability and affordability of orphan blood disease therapeutics in India |
4.3.2 Stringent regulatory requirements for drug approval and market entry |
4.3.3 Lack of skilled healthcare professionals specialized in treating rare diseases |
5 India Acquired Orphan Blood Diseases Therapeutics Market Trends |
6 India Acquired Orphan Blood Diseases Therapeutics Market, By Types |
6.1 India Acquired Orphan Blood Diseases Therapeutics Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Recombinantfactor, 2021- 2031F |
6.1.4 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Immuno globulin infusion therapy, 2021- 2031F |
6.1.5 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Activated prothrombin complex concentrate, 2021- 2031F |
6.1.6 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Thrombopoietin receptor agonists, 2021- 2031F |
6.2 India Acquired Orphan Blood Diseases Therapeutics Market, By Symptoms |
6.2.1 Overview and Analysis |
6.2.2 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Agranulocytosis, 2021- 2031F |
6.2.3 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Hemophilia, 2021- 2031F |
6.2.4 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Von Willebrand Syndrome, 2021- 2031F |
6.2.5 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Paroxysmal Nocturnal Hemoglobinuria, 2021- 2031F |
6.2.6 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Myelodysplastic Syndrome, 2021- 2031F |
6.3 India Acquired Orphan Blood Diseases Therapeutics Market, By DistributionChannels |
6.3.1 Overview and Analysis |
6.3.2 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4 India Acquired Orphan Blood Diseases Therapeutics Market, By Therapies Covered |
6.4.1 Overview and Analysis |
6.4.2 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Recombinant Factor, 2021- 2031F |
6.4.3 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Immunoglobulin Infusion Therapy, 2021- 2031F |
6.4.4 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Activated Prothrombin Complex Concentrate, 2021- 2031F |
6.4.5 India Acquired Orphan Blood Diseases Therapeutics Market Revenues & Volume, By Thrombopoietin Receptor Agonists, 2021- 2031F |
7 India Acquired Orphan Blood Diseases Therapeutics Market Import-Export Trade Statistics |
7.1 India Acquired Orphan Blood Diseases Therapeutics Market Export to Major Countries |
7.2 India Acquired Orphan Blood Diseases Therapeutics Market Imports from Major Countries |
8 India Acquired Orphan Blood Diseases Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted for orphan blood disease therapeutics in India |
8.2 Patient access to orphan blood disease therapeutics in different regions of India |
8.3 Adoption rate of novel treatment options for acquired orphan blood diseases |
8.4 Rate of successful drug approvals and market launches for rare disease therapeutics in India |
8.5 Investment and funding trends in the Indian orphan blood diseases therapeutics market |
9 India Acquired Orphan Blood Diseases Therapeutics Market - Opportunity Assessment |
9.1 India Acquired Orphan Blood Diseases Therapeutics Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 India Acquired Orphan Blood Diseases Therapeutics Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.3 India Acquired Orphan Blood Diseases Therapeutics Market Opportunity Assessment, By DistributionChannels, 2021 & 2031F |
9.4 India Acquired Orphan Blood Diseases Therapeutics Market Opportunity Assessment, By Therapies Covered, 2021 & 2031F |
10 India Acquired Orphan Blood Diseases Therapeutics Market - Competitive Landscape |
10.1 India Acquired Orphan Blood Diseases Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Acquired Orphan Blood Diseases Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |